Modeling alpha-synuclein pathology in a human brain-chip to assess blood-brain barrier disruptionIosif Pediaditakis(Foundation for Research and Technology Hellas), Katia Karalis(Boston Children's Hospital)Nature CommunicationsOctober 8, 202110.1038/s41467-021-26066-5Cited by 220SaveCiteExport RISWatch citationsRelated PapersBNN27, a 17-Spiroepoxy Steroid Derivative, Interacts With and Activates p75 Neurotrophin Receptor, Rescuing Cerebellar Granule Neurons from Apoptosis|Frontiers in Pharmacology|2016|35